Literature DB >> 16075288

Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats.

Akiyoshi Saitoh1, Yuji Yoshikawa, Kenji Onodera, Junzo Kamei.   

Abstract

RATIONALE: Recent studies have shown that endogenous opioid systems are associated with the regulation of emotional responses. In particular, it has been reported that delta-opioid receptors act naturally to inhibit stress and anxiety.
OBJECTIVE: The present study was designed to examine the possible involvement of opioid delta-receptor subtypes in the anxiety-related behavior in the elevated-plus-maze test.
METHODS: Six-week-old male Lewis rats were used. The total numbers of visits to the closed and open arms and the cumulative time spent and visits in the open arms were determined. Plasma corticosterone levels were measured by enzyme immunoassay.
RESULTS: Naltrindole (NTI), a delta-opioid receptor antagonist (3 mg/kg s.c.), induced a significant decrease in the percentages of time spent and visits in the open arms. Naltriben (NTB), a delta2-opioid receptor antagonist (3 mg/kg s.c.), but not 7-benzylidenenaltrexone, a delta1-opioid receptor antagonist, produced similar anxiety-related behaviors in the elevated plus-maze. These effects of NTI and NTB were antagonized by pretreatment with (+)-4-[(aR)-a-((2S,5R)-4-allyl-2,5-dimethyl-1piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC80), a delta-opioid receptor agonist. Furthermore, after exposure to the elevated plus-maze, the maximal increase in the plasma corticosterone level in NTI-treated rats was clearly higher than that in vehicle-treated rats. However, when NTI and SNC80 were coadministered, higher levels of plasma corticosterone were not seen after exposure to the elevated plus-maze.
CONCLUSION: These results suggest that endogenous delta2-opioid-receptor-mediated systems are involved in the regulation of anxiety-related behaviors and might play a physiologically important role in the regulation of adrenocortical activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16075288     DOI: 10.1007/s00213-005-0112-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  42 in total

Review 1.  Selective naltrexone-derived opioid receptor antagonists.

Authors:  A E Takemori; P S Portoghese
Journal:  Annu Rev Pharmacol Toxicol       Date:  1992       Impact factor: 13.820

2.  Coexistence of kappa- and delta-opioid receptors in rat spinal cord axons.

Authors:  M W Wessendorf; J Dooyema
Journal:  Neurosci Lett       Date:  2001-02-09       Impact factor: 3.046

3.  Stimulation of delta1- and delta2-opioid receptors produces amnesia in mice.

Authors:  M Ukai; A Takada; Y Sasaki; T Kameyama
Journal:  Eur J Pharmacol       Date:  1997-10-29       Impact factor: 4.432

4.  Selective antagonists at the opiate delta-receptor.

Authors:  J S Shaw; L Miller; M J Turnbull; J J Gormley; J S Morley
Journal:  Life Sci       Date:  1982 Sep 20-27       Impact factor: 5.037

5.  Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.

Authors:  T Vanderah; A E Takemori; M Sultana; P S Portoghese; H I Mosberg; V J Hruby; R C Haaseth; T O Matsunaga; F Porreca
Journal:  Eur J Pharmacol       Date:  1994-02-03       Impact factor: 4.432

6.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

7.  Naltrindole administration during the preweanling period and manipulation affect adrenocortical reactivity in young rats.

Authors:  B Fernández; M T Antelo; C Guaza; I Alberti; M L Pinillos; M P Viveros
Journal:  Brain Res Dev Brain Res       Date:  1999-01-11

8.  Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.

Authors:  DeWayne Townsend; Philip S Portoghese; David R Brown
Journal:  J Pharmacol Exp Ther       Date:  2003-10-20       Impact factor: 4.030

9.  Lack of involvement of delta-opioid receptor in mediating physical dependence at the hypothalamus-pituitary-adrenocortical (HPA) axis in the rat.

Authors:  M L Gonzalvez; M L Vargas; M V Milanés
Journal:  Gen Pharmacol       Date:  1994-07

10.  Raised corticosterone in the rat after exposure to the elevated plus-maze.

Authors:  S E File; H Zangrossi; F L Sanders; P S Mabbutt
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

View more
  26 in total

1.  Docking studies suggest ligand-specific delta-opioid receptor conformations.

Authors:  Vuk Micovic; Milovan D Ivanovic; Ljiljana Dosen-Micovic
Journal:  J Mol Model       Date:  2008-12-04       Impact factor: 1.810

2.  Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation.

Authors:  Le-sha Zhang; Jun Wang; Jian-chun Chen; Yi-min Tao; Yu-hua Wang; Xue-jun Xu; Jie Chen; Yun-gen Xu; Tao Xi; Xiao-wu Hu; Yu-jun Wang; Jing-gen Liu
Journal:  Acta Pharmacol Sin       Date:  2015-03-30       Impact factor: 6.150

Review 3.  Current research on opioid receptor function.

Authors:  Yuan Feng; Xiaozhou He; Yilin Yang; Dongman Chao; Lawrence H Lazarus; Ying Xia
Journal:  Curr Drug Targets       Date:  2012-02       Impact factor: 3.465

Review 4.  The delta opioid receptor: an evolving target for the treatment of brain disorders.

Authors:  Amynah A Pradhan; Katia Befort; Chihiro Nozaki; Claire Gavériaux-Ruff; Brigitte L Kieffer
Journal:  Trends Pharmacol Sci       Date:  2011-09-17       Impact factor: 14.819

5.  A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors.

Authors:  Jovita F Randall-Thompson; Karen A Pescatore; Ellen M Unterwald
Journal:  Psychopharmacology (Berl)       Date:  2010-08-21       Impact factor: 4.530

Review 6.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

Review 7.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

Review 8.  Endogenous opioid system: a promising target for future smoking cessation medications.

Authors:  Haval Norman; Manoranjan S D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2017-03-11       Impact factor: 4.530

9.  Delta opioid receptor ligands modulate anxiety-like behaviors in the rat.

Authors:  Shane A Perrine; Brian A Hoshaw; Ellen M Unterwald
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

10.  Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.

Authors:  Yu-Jun Wang; Yi-Min Tao; Fu-Ying Li; Yu-Hua Wang; Xue-Jun Xu; Jie Chen; Ying-Lin Cao; Zhi-Qiang Chi; John L Neumeyer; Ao Zhang; Jing-Gen Liu
Journal:  J Pharmacol Exp Ther       Date:  2009-01-09       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.